Thursday, December 18, 2014

Merck Acquires OncoEthix for Up to $375 Million

Merck & Co. acquired privately held OncoEthix for up to $375 million, its latest push into the oncology market as the pharmaceutical giant continues bolstering its research-and-development pipeline.



from WSJ.com: US Business http://ift.tt/1GvHDY8

via IFTTT

No comments:

Post a Comment